当前位置: X-MOL 学术Eur. Respir. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial
European Respiratory Journal ( IF 24.3 ) Pub Date : 2017-10-01 , DOI: 10.1183/13993003.01235-2017
Sara J Abdallah 1 , Courtney Wilkinson-Maitland 1 , Nathalie Saad 2, 3 , Pei Zhi Li 4 , Benjamin M Smith 1, 3, 4, 5, 6, 7, 8, 9 , Jean Bourbeau 3, 4, 5, 6, 7, 8, 9 , Dennis Jensen 3, 4, 5, 6, 7, 8, 9, 10
Affiliation  

The objective of the present study was to evaluate the effect of morphine on exertional breathlessness and exercise endurance in advanced chronic obstructive pulmonary disease (COPD). In a randomised crossover trial, we compared the acute effect of immediate-release oral morphine versus placebo on physiological and perceptual responses during constant-load cardiopulmonary cycle exercise testing (CPET) in 20 adults with advanced COPD and chronic breathlessness syndrome. Compared with placebo, morphine reduced exertional breathlessness at isotime by 1.2±0.4 Borg units and increased exercise endurance time by 2.5±0.9 min (both p≤0.014). During exercise at isotime, morphine decreased ventilation by 1.3±0.5 L·min−1 and breathing frequency by 2.0±0.9 breaths·min−1 (both p≤0.041). Compared with placebo, morphine decreased exertional breathlessness at isotime by ≥1 Borg unit in 11 participants (responders) and by <1 Borg unit in nine participants (non-responders). Baseline participant characteristics, including pulmonary function and cardiorespiratory fitness, were similar between responders and non-responders. A higher percentage of responders versus non-responders stopped incremental CPET due to intolerable breathlessness: 82 versus 33% (p=0.028). Immediate-release oral morphine improved exertional breathlessness and exercise endurance in some, but not all, adults with advanced COPD. The locus of symptom-limitation on laboratory-based CPET may help to identify patients most likely to benefit from morphine. Immediate-release oral morphine decreased exertional breathlessness and improved exercise endurance in advanced COPD http://ow.ly/mrHQ30dS2qS

中文翻译:

吗啡对晚期 COPD 患者呼吸困难和运动耐力的影响:一项随机交叉试验

本研究的目的是评估吗啡对晚期慢性阻塞性肺疾病 (COPD) 劳力性呼吸困难和运动耐力的影响。在一项随机交叉试验中,我们比较了 20 名患有晚期 COPD 和慢性呼吸困难综合征的成人在恒定负荷心肺循环运动测试 (CPET) 期间立即释放口服吗啡与安慰剂对生理和知觉反应的急性影响。与安慰剂相比,吗啡在等时减少劳力性呼吸困难 1.2±0.4 Borg 单位,增加运动耐力时间 2.5±0.9 分钟(均 p≤0.014)。在等时运动期间,吗啡使通气量减少 1.3±0.5 L·min−1,呼吸频率减少 2.0±0.9 次呼吸·min−1(均 p≤0.041)。与安慰剂相比,吗啡使 11 名参与者(响应者)在等时的劳力性呼吸困难减少 ≥ 1 Borg 单位,9 名参与者(无响应者)减少 <1 Borg 单位。响应者和无响应者的基线参与者特征,包括肺功能和心肺健康,相似。由于无法忍受的呼吸困难,有反应者与无反应者相比停止增量 CPET 的比例更高:82% 对 33% (p=0.028)。速释口服吗啡改善了一些(但不是全部)晚期 COPD 成人的劳力性呼吸困难和运动耐力。基于实验室的 CPET 症状限制的位置可能有助于识别最有可能从吗啡中受益的患者。速释口服吗啡可减少晚期 COPD 患者的劳力性呼吸困难并提高运动耐力 http://ow.
更新日期:2017-10-01
down
wechat
bug